Remedium Lifecare
Ticker > Company >

Remedium Lifecare share price

Remedium Lifecare Ltd.

BSE: 539561 SECTOR: Trading  53k   120   6

5.41
+0.10 (1.88%)
BSE: Today, 01:54 PM

Price Summary

Today's High

₹ 5.41

Today's Low

₹ 5.41

52 Week High

₹ 38.25

52 Week Low

₹ 5.29

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 218.13 Cr.

Enterprise Value

₹ 274.31 Cr.

No. of Shares

40.32 Cr.

P/E

11.81

P/B

4.75

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.14

CASH

₹ 1.52 Cr.

DEBT

₹ 57.7 Cr.

Promoter Holding

1.11 %

EPS (TTM)

₹  0.46

Sales Growth

692.75%

ROE

122.76 %

ROCE

99.51%

Profit Growth

503.2 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year692.75%
3 Year255.4%
5 Year660.29%

Profit Growth

1 Year503.2%
3 Year308.4%
5 Year427.68%

ROE%

1 Year122.76%
3 Year72.73%
5 Year48.03%

ROCE %

1 Year99.51%
3 Year73.4%
5 Year47.75%

Debt/Equity

1.3432

Price to Cash Flow

-2.94

Interest Cover Ratio

11.5476

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 1.11 0.00
Jun 2024 1.11 0.00
Mar 2024 1.11 0.00
Dec 2023 1.11 0.00
Sep 2023 1.11 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 308.399394038426% for the Past 3 years.
  • The company has shown a good revenue growth of 255.397255683973% for the Past 3 years.
  • Company has been maintaining healthy ROE of 72.7296% over the past 3 years.
  • Company has been maintaining healthy ROCE of 73.3995333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 11.5476.
  • The company has an efficient Cash Conversion Cycle of 19.3708 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 116.416474165369.

 Limitations

  • Company has negative cash flow from operations of -74.1611.
  • The company has a low EBITDA margin of 3.36658% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 468.57 1834.18 1408.49 77.7 25.08
Total Expenditure 462.23 1779.48 1443.52 77.31 20.62
Operating Profit 6.34 54.7 -35.03 0.39 4.46
Other Income 4.08 14.12 2.89 1.89 0.82
Interest 0 0.03 3.85 0 2.81
Depreciation 0.02 0.01 0.01 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 10.41 68.78 -36 2.27 2.46
Tax 3.88 0 17.72 0.63 0.68
Profit After Tax 6.53 68.78 -53.72 1.64 1.78
Adjusted EPS (Rs) 0.16 1.71 -1.33 0.04 0.04

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 2.89 90.03 504.79 509.84 4041.71
Total Expenditure 2.5 89.31 502.98 502.67 4007.51
Operating Profit 0.39 0.72 1.82 7.17 34.19
Other Income 0.01 0.01 0.01 0.83 21.1
Interest 0.01 0.02 0.23 0.45 4.78
Depreciation 0.01 0.06 0.07 0.15 0.06
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.38 0.65 1.53 7.4 50.45
Tax 0.1 0.17 0.45 1.97 17.72
Net Profit 0.28 0.48 1.08 5.43 32.73
Adjusted EPS (Rs.) 0.01 0.01 0.03 0.13 0.81

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.6 3.6 3.6 3.6 10.08
Total Reserves -0.25 0.26 1.34 6.76 32.88
Borrowings 0.36 10.5 0 0 0
Other N/C liabilities 0 0 0 -0.01 -0.03
Current liabilities 0.55 24.17 218.82 1143.86 1904.97
Total Liabilities 4.27 38.53 223.76 1154.22 1947.9
Assets
Net Block 0.23 0.21 0.19 0.08 0.05
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 4.04 38.32 223.57 1154.14 1947.85
Total Assets 4.27 38.53 223.76 1154.22 1947.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.38 0.65 1.53 7.4 50.45
Adjustment 0.01 0.06 0.18 0.19 3.84
Changes in Assets & Liabilities -0.59 -10.89 10.03 14.89 -110.64
Tax Paid 0 -0.04 -0.45 -1.98 -17.81
Operating Cash Flow -0.2 -10.21 11.28 20.5 -74.16
Investing Cash Flow -0.24 -0.04 -0.05 -0.04 0.09
Financing Cash Flow 0.29 10.14 -10.61 -0.04 53.74
Net Cash Flow -0.15 -0.11 0.62 20.42 -20.33

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 1.11 1.11 1.11 1.11 1.11
siddharth chimanlal shah 1.11 1.11 1.11 1.11 1.11
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 98.89 98.89 98.89 98.89 98.89
alok ashok tiwari 1.73 1.59 1.59 1.59 1.46
amit prakash masalia 1.89 1.89 1.89 1.89 1.89
chirag narendra modh 4.20 4.20 4.20 4.20 4.20
cnm finvest private limit... 5.45 5.45 5.45 4.59 4.59
deena prakash masalia 1.81 1.81 1.81 1.81 1.81
dhansukhbhai champaklal j... 2.64 2.64 2.64 2.64 2.64
jayashree d singh 1.60 1.60 1.60 1.60 1.60
jiteshkumar shashikantbha... 2.78 2.78 2.78 2.78 2.78
jyotika shenoy - - - - 2.06
kamlesh pravinchandra sha... 2.45 2.29 2.14 1.39 1.27
lalit kumar lalwani . 1.79 1.79 - - 1.16
maryam maqbool dhoki 1.94 1.94 1.94 1.94 1.12
mukesh kumar naresh 1.62 1.62 1.62 1.62 1.62
padmavathy kaimal kondath... 1.46 1.46 1.46 1.59 1.59
payal amit masalia 1.78 1.78 1.78 1.78 1.78
remedium escrow suspense ... - 4.39 - - 3.05
sadhana santhosh shanbhag... 1.11 1.11 - 1.06 1.06
sathish srinivas nayak - - - - 2.72
sheela rajendrakumar kaim... - - - 1.69 1.69
sudhakar jha 1.60 - - 1.60 1.55
uppinangady sudhindra nay... 8.10 7.94 - 7.47 6.99
vasanth kumar bantwal 1.67 1.67 1.67 1.55 1.55
venkatesh bhaskar shenoy 3.98 3.99 3.99 3.23 2.19
vignesh . 5.69 - - - 5.92
vishek . masalia 2.95 2.95 - 2.95 2.95
achintya securities priva... - - - 1.53 -
guruprasad sitaram kudva 1.46 1.46 1.46 1.19 -
jyotika deepak shenoy 6.54 5.55 5.26 3.19 -
kamlesh pravinchandra sha... 1.33 1.29 - 1.09 -
lalit kumar lalwani - - 1.79 1.63 -
radhika vasanth 1.14 1.14 - 1.04 -
sathish s nayak 3.78 3.78 3.78 3.42 -
tulsi arvindakshan nair - - 1.47 1.18 -
vignesh - - 5.69 5.94 -
achinya securities privat... - - 1.31 - -
kamlesh pravinchandra - - 1.24 - -
kapil mahesh kothari 1.40 1.40 1.00 - -
minal uday doshi 1.09 1.08 1.07 - -
radhika vasanth - - 1.14 - -
sadhana santhosh - - 1.11 - -
sheela rajendra kaimal 1.47 1.47 1.47 - -
uppinangady sudhindra - - 7.76 - -
vishek masalia - - 2.95 - -
tulasi arvindakshan nair 1.47 1.47 - - -
vignesh . - 5.69 - - -
heroic mercantile 1.15 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Remedium Lifecare informs about reconstitution of committees of board 31 Oct, 4:57 PM Remedium Lifecare informs about disclosure 4 Oct, 4:47 PM Remedium Lifecare - Quaterly Results 14 Aug, 8:15 PM Remedium Lifecare informs about receipt of order 29 Jul, 10:15 AM Remedium Lifecare enters into strategic agreement with Angel Partners 29 Jul, 9:44 AM Remedium Lifecare informs about outcome of board meeting 20 Jul, 4:12 PM Remedium Lifecare informs about receipt of order 25 Jun, 9:54 AM Remedium Lifecare receives contract from pharmaceutical distribution company in UK 25 Jun, 9:30 AM Remedium Lifecare - Quaterly Results 27 May, 9:23 PM Remedium Lifecare - Quaterly Results 27 May, 9:23 PM Remedium Lifecare informs about certificate 6 Apr, 1:55 PM Remedium Lifecare informs about compliance certificate 6 Apr, 12:45 PM Remedium Lifecare gets export order worth Rs 169 crore 28 Feb, 11:00 AM Remedium Lifecare informs about receipt of export order 28 Feb, 9:59 AM Remedium Lifecare to acquire manufacturing facility in Hyderabad 23 Feb, 11:53 AM Remedium Lifecare informs about board meeting 23 Feb, 10:28 AM Remedium Lifecare - Quaterly Results 14 Feb, 5:08 PM Remedium Lifecare - Quaterly Results 14 Feb, 5:08 PM Remedium Lifecare informs about record date 12 Feb, 10:53 AM Remedium Lifecare informs about issuance of duplicate share certificate 31 Jan, 10:00 AM Remedium Lifecare informs about RTA certificate 10 Jan, 2:55 PM Remedium Lifecare - Quaterly Results 11 Nov, 6:29 PM Remedium Lifecare - Quaterly Results 11 Nov, 6:29 PM Remedium Lifecare informs about certificate 21 Oct, 12:29 PM Remedium Lifecare informs about resignation of CS cum CO 8 Sep, 4:48 PM Remedium Lifecare - Quaterly Results 12 Aug, 2:54 PM Remedium Lifecare - Quaterly Results 12 Aug, 2:54 PM Remedium Lifecare informs about AGM notice and annual report 27 Jun, 9:55 AM Remedium Lifecare informs about AGM 26 Jun, 2:15 PM Remedium Lifecare informs about AGM 26 Jun, 12:39 PM Remedium Lifecare planning to increase borrowing limit by issuance of debt securities 15 Jun, 10:22 AM Remedium Lifecare - Quaterly Results 30 May, 8:14 PM Remedium Lifecare - Quaterly Results 30 May, 8:14 PM Remedium Lifecare informs about compliance certificate 19 Apr, 5:06 PM Remedium Lifecare informs about newspaper publication 9 Feb, 5:04 PM Remedium Lifecare - Quaterly Results 7 Feb, 5:49 PM Remedium Lifecare - Quaterly Results 7 Feb, 5:49 PM Remedium Lifecare - Quaterly Results 7 Feb, 5:49 PM Remedium Lifecare informs about scheme of arrangement 17 Dec, 10:23 AM Remedium Lifecare gets nod to merge MVK Lifesciences with itself 15 Nov, 5:41 PM Remedium Lifecare - Quaterly Results 4 Nov, 6:44 PM Remedium Lifecare - Quaterly Results 4 Nov, 6:44 PM Remedium Lifecare informs about outcome of 33rd AGM 20 Sep, 3:05 PM Remedium Lifecare - Quaterly Results 9 Feb, 6:19 PM Remedium Lifecare - Quaterly Results 9 Feb, 6:19 PM Remedium Lifecare informs about 32nd AGM 31 Aug, 10:03 AM Remedium Lifecare informs about newspaper clippings 12 Jul, 3:43 PM Remedium Lifecare informs about disclosure 14 Jun, 2:12 PM Remedium Lifecare informs about change in registered office address 12 May, 1:39 PM Remedium Lifecare submits disclosure 14 Apr, 1:06 PM

Remedium Lifecare Stock Price Analysis and Quick Research Report. Is Remedium Lifecare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Remedium Lifecare stock price today is Rs 5.41. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Remedium Lifecare . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Remedium Lifecare has a PE ratio of 11.8122270742358 which is low and comparatively undervalued .

  • Share Price: - The current share price of Remedium Lifecare is Rs 5.41. One can use valuation calculators of ticker to know if Remedium Lifecare share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Remedium Lifecare has ROA of 2.1102 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Remedium Lifecare has a Current ratio of 1.0225 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Remedium Lifecare has a ROE of 122.7641 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Remedium Lifecare has a Debt to Equity ratio of 1.3432 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Remedium Lifecare has reported revenue growth of 692.7455 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Remedium Lifecare for the current financial year is 0.84601388814284 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Remedium Lifecare is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Remedium Lifecare is Rs 0.458 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Remedium Lifecare in Ticker for free. Also, one can get the intrinsic value of Remedium Lifecare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Remedium Lifecare

Remedium Lifecare Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Remedium Lifecare Limited is a leading pharmaceutical company that specializes in the manufacturing and marketing of a wide range of healthcare products. The company was established in [year] and has since grown to become a trusted name in the industry.

Remedium Lifecare Limited: Share Price

The share price of Remedium Lifecare Limited is a key indicator for investors looking to analyze the company's performance in the stock market. Our website provides real-time share price updates, allowing investors to stay informed about the latest market trends.

Remedium Lifecare Limited: Balance Sheet

The balance sheet of Remedium Lifecare Limited offers insights into the company's financial health and stability. Investors can analyze key financial ratios and trends to make informed investment decisions. Our website provides downloadable annual reports that include balance sheets for easy reference.

Remedium Lifecare Limited: Annual Report

The annual report of Remedium Lifecare Limited provides a comprehensive overview of the company's performance over the past year. Investors can delve into details such as revenue growth, profitability, and future outlook. Our website offers downloadable annual reports to facilitate in-depth analysis.

Remedium Lifecare Limited: Dividend

Dividends are an important consideration for long-term stock investors. Remedium Lifecare Limited's dividend payout history can provide insights into the company's profitability and commitment to shareholder returns. Investors can find dividend information on our website, along with dividend history and payout ratios.

Remedium Lifecare Limited: Quarterly Result

Tracking the quarterly results of Remedium Lifecare Limited is crucial for investors. Our website provides access to downloadable quarterly reports, enabling investors to analyze revenue growth, profit margins, and other financial metrics. These reports can help investors assess the company's performance over shorter periods.

Remedium Lifecare Limited: Stock Price

The stock price of Remedium Lifecare Limited fluctuates in response to market conditions, industry trends, and company-specific factors. Investors can monitor the stock price on our website through real-time updates and interactive price charts. These tools assist investors in making informed decisions based on market trends.

Remedium Lifecare Limited: Price Chart

Our website offers interactive price charts that illustrate the historical performance of Remedium Lifecare Limited's stock. Long-term stock investors can analyze price patterns, trends, and volatility to understand the market sentiment around the company's stock. These charts provide valuable insights for investors.

Remedium Lifecare Limited: News and Updates

Stay updated with the latest news and updates about Remedium Lifecare Limited on our website. We curate relevant news articles, press releases, and market updates, ensuring investors have access to the latest information that could impact the company's stock performance.

Remedium Lifecare Limited: Concall Transcripts

Concall transcripts offer a detailed record of management discussions and question-answer sessions during conference calls. Our website provides downloadable concall transcripts for Remedium Lifecare Limited, allowing investors to gain insights into the company's strategy, outlook, and response to market conditions.

Remedium Lifecare Limited: Investor Presentations

Investor presentations provide a snapshot of Remedium Lifecare Limited's business model, strategies, and financial performance. Our website offers downloadable investor presentations that highlight the company's growth plans, competitive advantages, and key industry trends. Investors can use these presentations for a deeper understanding of the company's prospects.

Remedium Lifecare Limited: Promoters

The promoters of Remedium Lifecare Limited play a significant role in driving the company's growth and success. Investors can explore information about the promoters on our website, including their professional backgrounds, involvement in the company, and stakeholding. This information helps investors gauge the commitment and expertise of the company's key stakeholders.

Remedium Lifecare Limited: Shareholders

Understanding the shareholder base of Remedium Lifecare Limited is essential for investors. Our website provides information about major shareholders, institutional investors, and public shareholding. Investors can gain insights into the company's ownership structure and identify potential influencers on stock value and decision-making.

At our website, we offer pre-built screening tools that can help investors analyze Remedium Lifecare Limited's stock based on their preferred parameters. Additionally, premium features such as DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis are available to assist investors in calculating fair value and gaining a deeper understanding of the company's financials.

Please note that all downloadable resources, including annual reports, concall transcripts, investor presentations, credit ratings, and research reports, are provided on our website to facilitate comprehensive stock analysis for long-term investors.

Read More
X